A Phase Ib/II Study of AEB071 and MEK162 in Adult Patients With Metastatic Uveal Melanoma
Clinical trial NCT01801358 · TERMINATED
Trial details
- NCT number
- NCT01801358
- Sponsor
- Array Biopharma, now a wholly owned subsidiary of Pfizer
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-01
- Primary completion
- 2015-05-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.